A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
Stopped early · Phase 2
Conditions studied: Solid Tumor
In brief
A Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homologous Recombination Repair (HRR) genes.
Key facts
- Study ID
- NCT04171700
- Run by
- pharmaand GmbH
- People needed
- 83
- Starts
- 2020-01-16
- Expected to finish
- 2022-07-15
- Last updated by the study team
- 2023-10-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA Medicine Hematology and Oncology — Los Angeles, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Florida Cancer Specialists — Fort Myers, Florida, United States
- Florida Cancer Specialists — St. Petersburg, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University — Chicago, Illinois, United States
- University of Iowa Hospital and Clinics — Iowa City, Iowa, United States
- Beth Israel Deaconess Medical Cancer Surgical Pavilion — Boston, Massachusetts, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Columbia University Irving Medical Center — New York, New York, United States
- New York Cancer and Blood Specialists — Port Jefferson Station, New York, United States
- New York Cancer And Blood Specialists — The Bronx, New York, United States
- Ohio State University — Columbus, Ohio, United States
- Stephenson Cancer Center - The University of Oklahoma — Oklahoma City, Oklahoma, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
- UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- SCRI/Tennessee Oncology - Chattanooga — Chattanooga, Tennessee, United States
- Tennessee Oncology — Nashville, Tennessee, United States
- Seattle Cancer Care Alliance/University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.